Completed Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma NCT00183820 Conditions Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +14 more Locations Norris Comprehensive Cancer Center — Los Angeles, California, United States View Trial Details
